On July 17, Innovent Biologics fell 3.45% in regular trading, trading at HK$89.85/share, with turnover of HK$499 million.
Within the Biotechnology sector where Innovent Biologics belongs, the overall sector performance was broadly weak. Among individual stocks, Akeso down 10.71%, 3SBio down 10.55%, SKB Bioscience down 5.42%, BeiGene down 2.25%, Remegen down 8.65%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)